Applied Therapeutics, Inc.
(NASDAQ:APLT)
$3.11
0.44 (16.48%)
Open: 1:04 PM
APLT Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
APLT Stock Price Today
Applied Therapeutics, Inc. (APLT) stock rallied over 16.48% intraday to trade at $3.11 a share on NASDAQ. The stock opened with a gain of 5.99% at $2.83 and touched an intraday high of $2.85, rising 16.48% against the last close of $2.67. The Applied Therapeutics, Inc. in stock market went to a low of $2.54 during the session.
APLT Stock Snapshot
$2.67
Prev. Close
240.19 Million
Market Cap
$2.54
Day Low
$2.83
Open
N/A
Number of Shares
$2.85
Day High
N/A
P/E ratio
-1.32
EPS (TTM)
0.49
Cash Flow per Share
N/A
Free Float in %
-0.14
Book Value
3806479.00
Volume
APLT Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
545 Fifth AvenueNew York, NY 10017US
Website:https://www.appliedtherapeutics.com
Contact #:212 220 9226
Company Information
EmployeesN/A
Beta1.42
Sales or Revenue$10.66 Million
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Peers
Frequently Asked Questions
What is the current Applied Therapeutics, Inc. (APLT) stock price?
Applied Therapeutics, Inc. (NASDAQ: APLT) stock price is $3.11 in the last trading session. During the trading session, APLT stock reached the peak price of $2.85 while $2.54 was the lowest point it dropped to. The percentage change in APLT stock occurred in the recent session was 16.48% while the dollar amount for the price change in APLT stock was $0.44.
APLT's industry and sector of operation?
The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Healthcare sector. Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications.
Who are the executives of APLT?
Mr. Chids Mahadevan
Senior Vice President of Fin. & Interim Principal Financial Officer
Dr. Shoshana Shendelman Ph.D.
Chair of the Board of Directors, Founder, Pres, Chief Executive Officer & Sec.
Mr. Chids Mahadevan
Sr. VP of Fin. & Interim Principal Financial Officer
Mr. Steven Ortega
Chief Accounting Officer
How APLT did perform over past 52-week?
APLT's closing price is 2.02% higher than its 52-week low of $0.64 where as its distance from 52-week high of $3.11 is -0.31%.
How many employees does APLT have?
Number of APLT employees currently stands at N/A. APLT operates from 545 Fifth Avenue, New York, NY 10017, US.
Link for APLT official website?
Official Website of APLT is: https://www.appliedtherapeutics.com
How do I contact APLT?
APLT could be contacted at phone #212 220 9226 and can also be accessed through its website. APLT operates from 545 Fifth Avenue, New York, NY 10017, US.
How many shares of APLT are traded daily?
APLT stock volume for the day was 3806479.00 shares. The average number of APLT shares traded daily for last 3 months was 1.03 Million.
What is the market cap of APLT currently?
The market value of APLT currently stands at $240.19 Million with its latest stock price at $3.11 and N/A of its shares outstanding.